KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $567,339 | -65.8% | 40,294 | -63.6% | 0.00% | -60.0% |
| Q4 2022 | $1,657,088 | +147.3% | 110,620 | +112.1% | 0.01% | +150.0% |
| Q3 2022 | $670,000 | +103.6% | 52,151 | +53.8% | 0.00% | +100.0% |
| Q2 2022 | $329,000 | -21.9% | 33,915 | -19.9% | 0.00% | -50.0% |
| Q1 2022 | $421,000 | -33.7% | 42,331 | -21.6% | 0.00% | -33.3% |
| Q4 2021 | $635,000 | +38.0% | 53,960 | +33.5% | 0.01% | 0.0% |
| Q3 2021 | $460,000 | +105.4% | 40,406 | +151.1% | 0.01% | +100.0% |
| Q2 2021 | $224,000 | -45.1% | 16,093 | -26.9% | 0.00% | -40.0% |
| Q1 2021 | $408,000 | -22.4% | 22,029 | -26.0% | 0.01% | -28.6% |
| Q4 2020 | $526,000 | +43.7% | 29,753 | +24.6% | 0.01% | +40.0% |
| Q3 2020 | $366,000 | -41.4% | 23,880 | -2.6% | 0.01% | -54.5% |
| Q2 2020 | $625,000 | +171.7% | 24,516 | +64.8% | 0.01% | +83.3% |
| Q1 2020 | $230,000 | +32.2% | 14,880 | -5.3% | 0.01% | +100.0% |
| Q4 2019 | $174,000 | +5700.0% | 15,705 | +4492.1% | 0.00% | – |
| Q3 2019 | $3,000 | -66.7% | 342 | -51.1% | 0.00% | – |
| Q2 2019 | $9,000 | -92.2% | 700 | -89.4% | 0.00% | -100.0% |
| Q2 2018 | $115,000 | – | 6,619 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |